Oszczędź do
0%
w porównaniu do średnich cen w Wielkiej Brytanii lub USA
Redaktor medyczny
Fahad Mawlood| Turcja | Austria | Hiszpania | |
| Wymiana plazmy | od $3,900 | - | - |
| Plazmafereza DFPP | od $1,850 | - | - |
| Afereza terapeutyczna | od $1,350 | - | - |
Turkey is a leading destination for myeloma care. Expert teams have performed 3,000+ bone marrow transplants since 2010. Hospitals often hold JCI accreditation. They offer immediate access to specialized hematology units. This eliminates long waiting lists found in other countries.
Bookimed Expert Insight: Turkey's hematology centers, such as Anadolu Medical Center, are official partners of Johns Hopkins Medicine. This partnership gives patients access to international treatment protocols. Top doctors here have 20+ years of experience. Many trained at prestigious US cancer centers. This ensures a high level of clinical expertise.
What patients say: Patients often mention their treatment in Turkey was an excellent experience. They note the medical staff is efficient. People traveling to Turkey appreciate the accessibility and affordability of care.
Republic of Korea excels in Myeloma treatment with top hospitals like Severance Hospital, Asan Medical Center, and Seoul National University Bundang Hospital (SNUBH). Severance Hospital is accredited by the Joint Commission International. Asan Medical Center is notable for high success rates in organ transplants and Myeloma treatment, attracting global medical tourists. SNUBH utilizes its BESTcare system for enhanced precision and safety.
Innovative procedures in Korea include autologous stem cell transplantation, CAR T-cell therapy, monoclonal antibody treatment, and proteasome inhibitor therapy. The Myeloma treatment success rate in Korea reaches 70%, highlighting the effectiveness of early diagnosis and personalized treatment plans.
Mexico is emerging as a notable destination for Myeloma treatment, with several clinics offering advanced therapies. Alivia Clinica Monterrey is among the leading facilities providing innovative treatment options. The clinic is committed to utilizing cutting-edge procedures such as CAR T-cell therapy, bispecific antibodies, and stem cell transplantation. The use of bispecific antibodies has shown promising results in enhancing treatment efficacy, as detailed in a recent study here.
The presence of internationally recognized accreditation bodies, such as the Joint Commission International, assures patients of the quality and safety standards maintained by clinics in Mexico. The combination of advanced treatment options and adherence to international standards positions Mexico as a promising option for Myeloma patients seeking effective care.
Wybór kraju do leczenia Szpiczak mnogi za granicą nie powinien być zgadywaniem. Pomogliśmy ponad 900 pacjentom, więc wiemy, które miejsca łączą najlepszych specjalistów, najbezpieczniejsze szpitale i przystępne ceny. Jesteśmy tu, by pomóc Ci znaleźć właściwy.